APHD-012: Mimicking Gastric Bypass Effects APHD-012 is an innovative oral medication designed to mimic the metabolic effects of gastric bypass surgery, offering a less invasive alternative for weight loss and glucose control
People with diabetes who develop a complication known as neuropathy may experience an array of symptoms, including pain, numbness, burning, tingling, or cramps
For example, in the ZUMA-1 trial (NCT02348216), KTE-C19 (axicabtagene ciloleucel) achieved a complete remission rate of 39% in patients with DLBCL
This is one of the main reasons people gain weight back after stopping GLP-1 therapy
Compared with naltrexone-bupropion, both medications were generally associated with lower hazards of anxiety and depression
What is a lipotropic B12 injection